Does GLIMEPIRIDE Cause Interstitial lung disease? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Interstitial lung disease have been filed in association with GLIMEPIRIDE (Glimepiride). This represents 0.4% of all adverse event reports for GLIMEPIRIDE.
22
Reports of Interstitial lung disease with GLIMEPIRIDE
0.4%
of all GLIMEPIRIDE reports
6
Deaths
12
Hospitalizations
How Dangerous Is Interstitial lung disease From GLIMEPIRIDE?
Of the 22 reports, 6 (27.3%) resulted in death, 12 (54.5%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLIMEPIRIDE. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does GLIMEPIRIDE Cause?
Hypoglycaemia (1,403)
Blood glucose increased (446)
Acute kidney injury (339)
Drug ineffective (339)
Diarrhoea (257)
Blood glucose decreased (232)
Lactic acidosis (219)
Glycosylated haemoglobin increased (214)
Diabetes mellitus inadequate control (213)
Hypoglycaemic coma (187)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which GLIMEPIRIDE Alternatives Have Lower Interstitial lung disease Risk?
GLIMEPIRIDE vs GLIMEPIRIDE\ROSIGLITAZONE
GLIMEPIRIDE vs GLIPIZIDE
GLIMEPIRIDE vs GLIVEC
GLIMEPIRIDE vs GLOFITAMAB
GLIMEPIRIDE vs GLOFITAMAB-GXBM